Avitar (AVTI) Stock Analysis & Winston Score

Avitar, Inc. is a small medical device company that makes diagnostic testing products. Its core product line has historically focused on oral fluid collection devices, which are used to collect saliva samples for drug testing and disease detection. Its main customers include healthcare providers, laboratories, and workplace drug-testing programs.

The company earns revenue by selling its collection devices and related diagnostic products, primarily in the United States. Avitar is a very small company, with a market cap near zero, and it operates in a competitive space alongside larger diagnostics firms with greater resources. The deeply negative return on invested capital signals the company has struggled to generate profits from its assets, and the key risk it faces is whether it can scale revenue fast enough to achieve sustainable profitability before running out of financial runway.

Winston Score History

Growth Profile

For growth stock investors

When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.

Revenue Growth

-52.8% YoY

YoY Growth Rate

Revenue declining

EPS Growth

+33.5% YoY

YoY Growth Rate

EPS growth accelerating

Insider Activity

0.0%ownership

→ Flat

Insiders holding steady — not selling despite ability to

Cash Runway

~1 months

$94,069 cash & investments

Quarterly Free Cash Flow

→ Burn rate stable

Short runway — potential dilution ahead through share issuance

Cash watch

Avitar has less than a year of cash at its current burn rate. Growth investors should watch for potential share dilution from future fundraising — that directly reduces your ownership.

The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Gross Margin

29.9%

Modest — 29.9% gross margin

Operating Margin

89.6%

Excellent — 89.6% operating margin

ROCE

N/A

—

Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales YoY

-47.4%

Shrinking sales (-47.4% YoY)

EPS YoY

N/A

Data not available

EPS Consistency

2/8 quarters

Earnings rarely grow — volatile business

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Cash Conversion

N/A

Data not available

FCF Margin

-75.4%

Burning cash (-75.4%)

Free cash flow is negative. They are burning cash, not generating it.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

Debt / Equity

N/A

—

Data not available

Interest Cover

3.55x

Tight — interest eats into profit (3.6x)

Interest coverage between 3 and 8. Profits cover interest several times over.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

P/E Ratio (TTM)

N/M

no trend

Negative earnings — P/E not meaningful

P/E vs Forward

N/A

not available

Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Not applicable for this business.

🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.

Start free trial